Most people notice reduced appetite within the first one to two weeks of starting Wegovy, but meaningful weight loss takes longer. You won’t reach the full maintenance dose until at least week 17, and clinical trials show the most significant results at the 68-week mark. Understanding this timeline helps set realistic expectations for each phase of treatment.
What Happens in the First Few Weeks
Semaglutide, the active ingredient in Wegovy, has a half-life of roughly one week. That means each weekly injection builds on the last, and the drug reaches a stable level in your bloodstream after about four to five weeks of consistent dosing. During this buildup period, many people notice subtle shifts: slightly less hunger between meals, feeling full sooner at meals, and finding it easier to pass on snacks. Some people feel these changes within days of their first injection, while others don’t notice much difference for a few weeks.
The early weeks aren’t designed for dramatic weight loss. You start on the lowest dose (0.25 mg per week), which is intentionally small to let your body adjust and minimize nausea and other digestive side effects. Any weight you lose during month one is a bonus, not the goal.
The Dose Escalation Schedule
Wegovy follows a structured ramp-up over 16 weeks before you reach the full maintenance dose. The FDA-approved schedule looks like this:
- Weeks 1 through 4: 0.25 mg once weekly
- Weeks 5 through 8: 0.5 mg once weekly
- Weeks 9 through 12: 1 mg once weekly
- Weeks 13 through 16: 1.7 mg once weekly
- Week 17 onward: 2.4 mg once weekly (maintenance dose)
Each step up tends to bring a noticeable boost in appetite suppression. Many people report that the jump from 0.5 mg to 1 mg, around weeks 9 through 12, is when weight loss starts to feel more consistent. But you’re not getting the drug’s full effect until you’ve been on the 2.4 mg maintenance dose for several weeks and it has built up to a steady level. That puts meaningful, sustained weight loss starting somewhere around weeks 20 to 24 for most people.
If side effects are too intense at any step, your prescriber may keep you at a lower dose for longer. The 1.7 mg dose is also approved as an alternative maintenance dose for people who can’t tolerate 2.4 mg.
Realistic Weight Loss Over Time
The landmark clinical trial (STEP 2) tested semaglutide 2.4 mg in adults with overweight or obesity and type 2 diabetes over 68 weeks. Participants lost an average of 9.6% of their body weight, compared to 3.4% in the placebo group. For someone starting at 250 pounds, that translates to roughly 24 pounds over about 16 months.
Weight loss with Wegovy isn’t linear. The pattern typically looks like this: slow progress during the first few months of dose escalation, a steeper decline once you’re on the maintenance dose, and then a gradual plateau somewhere between months 12 and 18. Most of the total weight loss happens in the first year, with results leveling off after that.
People without type 2 diabetes tend to lose a higher percentage of their body weight on semaglutide than those with diabetes. Individual results vary widely based on starting weight, diet, physical activity, genetics, and how well you tolerate the medication.
How to Tell if It’s Working
The clearest early signal isn’t the number on the scale. It’s the change in how hunger feels. You may find that portions that used to seem normal now feel like too much food. Cravings for high-calorie foods may lose some of their pull. These appetite changes are the drug’s primary mechanism: it mimics a hormone that signals fullness to your brain.
For the scale, a reasonable check-in point is after you’ve been on the maximum tolerated dose for 12 to 16 weeks. Clinical guidelines suggest that if you haven’t lost at least 5% of your body weight after three months on the full dose, continuing the medication is unlikely to produce meaningful results. At that point, your prescriber would typically reassess whether Wegovy is the right fit or whether a different approach makes more sense.
Keep in mind that 5% of body weight, while it sounds modest, produces real health improvements in blood pressure, blood sugar, joint stress, and cardiovascular risk. Weight loss of 10% or more brings even larger benefits, and many people on Wegovy exceed that threshold given enough time.
Factors That Speed or Slow Your Progress
Wegovy works best as part of a broader approach. In clinical trials, all participants also followed a reduced-calorie diet and increased their physical activity. The medication makes those changes easier by reducing hunger, but it doesn’t replace them. People who pair Wegovy with consistent lifestyle changes tend to see faster and larger results than those relying on the drug alone.
Certain medications can slow weight loss or cause weight gain, potentially blunting Wegovy’s effects. Sleep quality and stress levels also influence appetite hormones and metabolism in ways that can affect your trajectory. If your progress stalls, these are worth examining before assuming the medication isn’t working.
Alcohol adds calories your body processes preferentially over stored fat, and many people find their alcohol tolerance drops noticeably on semaglutide. Cutting back on drinking often accelerates results for people who were regular drinkers before starting treatment.
Beyond Weight Loss
Some benefits of Wegovy show up on different timelines than the number on the scale. Blood sugar improvements can begin within weeks, even before significant weight loss occurs, because semaglutide directly enhances insulin function. Blood pressure and cholesterol levels typically improve more gradually, tracking with the amount of weight lost over months.
Wegovy is also FDA-approved for reducing cardiovascular risk in adults with obesity and established heart disease. Those protective effects build over time and are linked to both the weight loss itself and direct effects of the drug on inflammation and blood vessel health. These benefits continue to accumulate well beyond the point where weight loss plateaus.